Aging

Medicare Advantage Plans Send Pals to Seniors’ Homes for Companionship — And Profits

Many Medicare Advantage plans send caregivers to the homes of seniors periodically to help with housework and provide companionship. But the workers may also prod seniors into activities that boost the plans’ Medicare ratings and federal reimbursements.

Despite Seniors’ Strong Desire to Age in Place, the Village Model Remains a Boutique Option

Membership-based villages help arrange services for seniors — such as handyman help or transportation to appointments — and provide social connections through classes, leisure opportunities, or community events. Despite great promise, they have been slow to expand because of difficulties raising funding and keeping people interested.

Patients Divided Over Alzheimer’s Drug: Is It a ‘Risk I’m Willing to Take’ or Just a ‘Magic Pill’?

Medicare has proposed limiting coverage of Aduhelm, the costly new drug to treat Alzheimer’s disease, and several prominent groups representing patients and their families are pressing the program to make it more widely available. But among individuals facing the disease, the outlook is more nuanced.

Seeking to Shift Costs to Medicare, More Employers Move Retirees to Advantage Plans

Private and public employers are increasingly using the government’s Medicare Advantage program as an alternative to their existing retiree health plan and traditional Medicare coverage. As a result, the federal government is paying the “overwhelming majority” of medical costs, according to an industry analyst.

Biden’s Promise of Better Nursing Home Care Will Require Many More Workers

The president wants to set minimum staffing levels for the beleaguered nursing home industry. But, given a lack of transparency surrounding the industry’s finances, it’s a mystery how facilities will shoulder the added costs.

KHN’s ‘What the Health?’: FDA Takes Center Stage

Congress is set to start its once-every-five-years review of the law that authorizes user fees to finance the hiring of personnel to speed the FDA review of drugs. The periodic renewals of “PDUFA” also give lawmakers a chance to make other changes to the agency at the hub of the pandemic. Meanwhile, the FDA could also find itself at the center of the abortion debate and a controversial new medication to treat Alzheimer’s disease. Anna Edney of Bloomberg News, Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, and Sarah Karlin-Smith of the Pink Sheet join KHN’s Julie Rovner to discuss these issues and more.

In California Nursing Homes, Omicron Is Bad, but So Is the Isolation

Omicron infections are surging in residential care facilities, causing massive sickouts among staff members and an uptick in hospitalizations and deaths. The latest visitor restrictions and testing requirements are also compounding the isolation that residents have suffered for almost two years.

Families Complain as States Require Covid Testing for Nursing Home Visits

Relatives say it is important they be allowed to go into nursing homes because staff shortages are affecting care. And many are still upset about lengthy separations from loved ones during lockdowns earlier in the pandemic.